Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Carter's (CRI) Q3 Fiscal 2026 Earnings Preview: Guidance and Investor Focus Areas

Carter's (CRI) Q3 Fiscal 2026 Earnings Preview: Guidance and Investor Focus Areas

Key Takeaways

  • Carter's, Inc. (NYSE: CRI) is scheduled to report third quarter fiscal 2026 results before the market opens on Friday, October 30, 2026.
  • Management has guided to net sales of roughly $750 million and approximately $0.85 in adjusted diluted earnings per share (EPS) for the quarter.
  • Wall Street consensus is centered near $0.85 to $0.89 in EPS and roughly $750 million in revenue, with estimates edging lower over the past two months.
  • A year ago, Carter's delivered adjusted EPS of $0.74 on $757.84 million in net sales, setting a relatively modest growth bar.
  • Investors will focus on U.S. Retail comparable sales, following five consecutive quarters of positive growth and a 5.1% gain last quarter.
  • For more context, you can review the ticker's Major News, Today's Price Move, Price Targets, and Forecast on additional pages.
  • Explore Trending AI Robots for automated, data-driven trading ideas across the market.

Why This Earnings Report Matters

Carter's stands as North America's largest dedicated baby and young children's apparel company, making its quarterly results a useful gauge of consumer demand for children's essentials. The firm has been navigating a multi-year turnaround backed by improved marketing, productivity efforts, and renewed strength in its core Baby segment. Its most recent quarter showed net sales up 5% and adjusted operating income up 54% year over year, though a one-time tariff refund provided some support. With Wall Street growing more cautious amid soft demand, higher input costs, and ongoing pressure from declining U.S. birth rates, this report will help clarify whether recent progress can hold up without temporary boosts.

What the Numbers Are Expected to Show

For the third quarter of fiscal 2026, management has guided to approximately $750 million in net sales, about $50 million in adjusted operating income, and roughly $0.85 in adjusted diluted EPS. In the year-ago quarter, the company reported $757.84 million in net sales and $0.74 in adjusted diluted EPS. Consensus estimates sit in a comparable range, with analysts generally looking for EPS of roughly $0.85 to $0.89 and revenue near $750 million. This points to modest year-over-year earnings growth against a slightly softer top line. Notably, consensus EPS estimates have drifted lower over the past 60 days as caution grows around margin pressure from cotton and oil prices along with softer consumer demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors will pay close attention to U.S. Retail comparable sales, gross margin trends, and any updates to the full-year 2026 outlook, which currently calls for 2% to 3% net sales growth.

Investor Sentiment Ahead of the Release

Sentiment heading into the report appears cautious. The stock recently traded near $32.60, toward the lower half of its 52-week range of roughly $27.86 to $44.44, and analyst ratings lean toward a neutral "Hold." Several firms have trimmed price targets in recent weeks, pointing to soft demand, unfavorable weather, and input-cost inflation. Elevated short interest also reflects meaningful skepticism about the turnaround. Because last quarter's results included a one-time tariff refund recovery, investors are likely to reward evidence of sustainable, organic operating improvement rather than another headline beat driven by non-operating items. A clean quarter with solid comparable sales and stable margins would carry more weight than EPS upside from temporary factors. Conversely, any disappointment on the top line or a downbeat fourth-quarter outlook could reinforce existing bearish positioning.

Looking Ahead: Factors to Keep an Eye On

Beyond the headline numbers, several elements could influence results over the next several quarters. First, guidance for the fourth quarter and any commentary on fiscal 2027 comparisons will matter, given the holiday period's outsized contribution to annual earnings. Second, margin trends remain important. Carter's has noted incremental tariff costs and input inflation, and rising cotton and oil prices could pressure gross margins even as the company pursues pricing actions, tariff mitigation, and productivity savings. The balance between those savings and demand-creation investments will help determine whether profitability continues to improve. Third, the structural decline in U.S. birth rates means Carter's must increasingly gain market share through brand relevance, digital growth, and store-fleet rationalization. Progress in the Baby segment and e-commerce channel will serve as key indicators. Finally, the balance sheet and return of capital remain supportive with a quarterly dividend and continued buyback flexibility, though expectations should stay grounded in reported data and management guidance.

Enhancing Research with AI Tools

In my own review of names like this, I often turn to Tickeron's AI tools to cross-check patterns and peer comparisons quickly. The AI Screener stands out for filtering stocks by industry, technical signals, and performance metrics, helping surface ideas that might otherwise take longer to identify manually. It has become a regular part of how I build context around upcoming reports.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CRI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CRI turned positive on November 04, 2026. Looking at past instances where CRI's MACD turned positive, the stock continued to rise in 40 of 55 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CRI as a result. In 62 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

CRI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRI crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in 194 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 109 of 189 cases where CRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

CRI broke above its upper Bollinger Band on November 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.144) is normal, around the industry mean (1.858). P/E Ratio (5.972) is within average values for comparable stocks, (12.576). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (0.517). Dividend Yield (0.031) settles around the average of (0.067) among similar stocks. P/S Ratio (0.346) is also within normal values, averaging (0.652).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. CRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are TJX Companies (NYSE:TJX), lululemon athletica (NASDAQ:LULU), Gap Inc (The) (NYSE:GAP), Abercrombie & Fitch Co (NYSE:ANF), Stitch Fix (NASDAQ:SFIX).

Industry description

Companies in the apparel and/or footwear retail industry sell clothing, accessories and footwear, for different age groups and genders. The industry’s product categories could range from basics, such as underwear, to luxury items. Some retailers source items from wholesalers or an apparel brand to sell in their stores; some others are licensed to make and market their own retail goods under particular brands. Several companies outsource production of clothing to developing/emerging economies where labor costs are relatively inexpensive. Apparel retail is often influenced by fashion trends, and many companies feel the need to adapt to what’s “in vogue” to retain customers and attract new ones. A major disruption in this industry has been the burgeoning trend in digital shopping – to compete with rapidly growing e-commerce, even traditional retail players are upping the ante on their online platforms. Much of the products’ performance in apparel/footwear retail is cyclical, i.e., economic boom times encourage consumer spending, while recessions induce thriftiness among people. Some large-cap U.S. apparel/footwear retail companies include TJX Companies Inc., Ross Stores, Inc., Lululemon Athletica Inc. and Burlington Stores, Inc.

Market Cap

The average market capitalization across the Apparel/Footwear Retail Industry is 8.95B. The market cap for tickers in the group ranges from 131.6K to 189.04B. IDEXF holds the highest valuation in this group at 189.04B. The lowest valued company is DESTQ at 131.6K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Retail Industry was -6%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -13%. MYSZ experienced the highest price growth at 28%, while LVLU experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Retail Industry was 100%. For the same stocks of the Industry, the average monthly volume growth was 154% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 52
Price Growth Rating: 60
SMR Rating: 64
Profit Risk Rating: 85
Seasonality Score: 18 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of apparel and related products for babies and young children

Industry ApparelFootwearRetail

Industry
Apparel Or Footwear Retail
Address
3438 Peachtree Road North East
Phone
+1 678 791-1000
Employees
15400
Web
https://www.carters.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.